Strategic Advocates’s ASML ASML Stock Holding History

Strategic Advocates’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$4.29K	–	292
2025 Q4	$4.29K	Hold	4	–	–	﹤0.01%	443
2025 Q3	$3.87K	Buy	+4	New	+$3.14K	﹤0.01%	435

Other funds holding ASML

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Strategic Advocates's ASML Position: Q1 2026 in Review

Strategic Advocates sold out of ASML (ASML) in Q1 2026, closing a stake of 4 shares — an estimated $4.29K sold.

Strategic Advocates first reported a position in ASML in Q3 2025 and held it in 2 quarters. The position peaked at $4.29K in Q4 2025. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

Strategic Advocates reported no remaining ASML position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 4 ASML shares in Q1 2026, an estimated $4.29K.
Strategic Advocates first reported a position in ASML in Q3 2025 and held it in 2 quarters.
Strategic Advocates's ASML position peaked at $4.29K in Q4 2025.
2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.